The global sleep apnea diagnostic & therapeutic device market is expected to exceed more than US$ 7 billion by 2022, registering a compound annual growth rate (CAGR) of 7.5% during the forecast period. The growing awareness regarding the ill effects of untreated sleep apnea, the growing usage of oral appliances, technological advancements, and the large pool of undiagnosed sleep apnea patients are factors attributed to the growth of the market. However, the high cost of diagnostic procedures, increased discomfort levels, and the need for patient compliance with therapeutic devices are expected to hamper the growth of the market.
In this report, the global sleep apnea diagnostic & therapeutic device market is segmented by diagnostic device, therapeutic device, and region. On the basis of diagnostic device, the market is segmented into actigraphy systems, respiratory polygraph, polysomnography (PSG) device, and single-channel screening devices. The market on the basis of therapeutic device is segmented into airway clearance systems, positive airway pressure (PAP) device, adaptive servo-ventilation (ASV), oxygen devices, oral appliances, and others.
The global sleep apnea diagnostic & therapeutic device market is segmented on the basis of key regions, namely, North America, Europe, Asia Pacific, and Rest of the World. Furthermore, each region is segmented to provide market revenue for select countries such as the U.S., Canada, the U.K., Germany, China, Japan, India, Brazil, and GCC countries. The report includes a detailed study of the global and regional sleep apnea diagnostic & therapeutic device market and analyzes the variations in the growth of the industry in certain regions.
A glimpse of the report structure is provided in the report description available on the website.
Phillips Healthcare, BMC Medical Co. Ltd., Braebon Medical Corporation, Cadwell Laboratories, CareFusion Corp., Compumedics Limited, Curative Medical Inc., Fisher & Paykel Healthcare, GE Healthcare, ImThera Medical Inc., Invacare Corporation, Nihon Kohden, and ResMed are the most active players in the sleep apnea diagnostic & therapeutic device market.
This report covers the sleep apnea diagnostic & therapeutic device market, in terms of value, and forecasts the market size till 2022. In addition, the report identifies key growth segments and opportunities in the industry. This report also covers detailed competitive outlook including the share and company profiles of the key players in the global sleep apnea diagnostic & therapeutic device market. Company profile includes company summary, financial summary, business strategy and planning, SWOT analysis, and current developments.
The deep-dive study on the sleep apnea diagnostic & therapeutic device market will help customers with identifications of new market opportunities and targeted promotional plans.
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact email@example.com